Genes such as BRCA1 and BRCA2, which have high penetrance, have received much attention, while moderate-risk genes such as ATM and CHEK2 are increasingly being known for their considerable percentage in increasing BC risk (Table 1). This evidence concerns the gene BRCA2 and breast cancer.